Issue link: https://beckershealthcare.uberflip.com/i/704577
19 PRACTICE MANAGEMENT SPINE DEVICE & INNOVATION Medtronic, NuVasive Lead US MIS Interbody Fusion Market: 7 Observations By Megan Wood T he U.S. minimally invasive spine fusion market is anticipated to surpass $1.15 billion by 2021, based on an iData Research report, according to Digital Journal. Here are seven observations: 1. A MIS interbody fusion procedure average selling price is greater than that of a single-level procedure alone. 2. Hospitals and payers will hinder MIS inter- body fusion market growth due to high prices. 3. Lateral lumbar interbody fusion proce- dures possess the highest average selling price and will experience the fastest growth rate in the market. is is because of higher interbody device costs and a higher number of procedure levels. NuVasive's XLIF approach is the most popu- lar product in the LLIF segment. Medtronic's Direct Lateral Interbody Fusion procedure is also popular. 4. Minimally invasive tranforaminal lumbar interbody fusion procedures account for the greatest portion of total MIS interbody procedures performed. is segment will continue to dominate to 2021. 5. Medtronic dominates the MIPLIF and MITLIF segments, and leads the MIS inter- body fusion market. e company offers various MIS systems: Minimal Exposure Tubular Retractor system; CD Horizon Sextant percutaneous cannu- lated screw system; CD Horizon Legacy percutaneous PEEK rod system; and CD Horizon Longitude. 6. NuVasive follows Medtronic in market dominance. e company offers various products to complement its XLIF procedure: SLP Plus lateral plating system; Radian facet screw system; and Affix II spinous process plating systems. 7. Other key market players include DePuy Synthes, Globus Medical, Stryker, K2M, Zimmer Biomet, Pioneer Surgical, Alphatec Spine and Aurora Spine. n Medtronic Acquires Med-Tech Start-Up Responsive Orthopedics: 5 Things to Know By Anuja Vaidya M edtronic has acquired Responsive Orthopedics, a start-up aiming to sell lower cost knee and hip devices, according to a Star Tribune report. Here are five things to know: 1. Doug Kohrs and two partners started Responsive Or- thopedics and funded it themselves. 2. The company focuses on developing devices with "streamlined size offerings and instrument sets," accord- ing to the report. The company aims to lower devices' cost by up to 40 percent by changing the distribution process. 3. The company also sells devices to healthcare providers and facilities participating in federal programs, such as CMS' Comprehensive Care for Joint Replacement. How- ever, it will not sell physician-owned distributorships. 4. The FDA cleared Responsive Orthopedics' total knee replacement last year, and the company is in the process of developing a total hip replacement system. 5. The acquisition deal was private and terms of the trans- action were not disclosed. n NuVasive Acquires Biotronic for $98M: 6 Things to Know By Anuja Vaidya N uVasive entered into a definitive agreement to acquire Biotronic NeuroNetwork for $98 million in cash. Here are six things to know: 1. Biotronic is a provider of intraoperative neurophysi- ological monitoring services. The company provides re- al-time remote monitoring through proprietary software and a secure, virtual network. 2. The acquisition aims to enhance NuVasive's spine ser- vice line offerings through improved surgical monitoring and oversight capabilities. 3. Following the close of the transaction, NuVasive plans to combine the service offerings of Biotronic with its subsidiary, Impulse Monitoring, to create NuVasive Clinical Services. 4. Both companies' board of directors have unanimously approved the transaction. 5. NuVasive expects the transaction to be immediately accretive to its non-GAAP earnings-per-share in 2016 and significantly accretive in 2017 and beyond. 6. The transaction closed in July. n